{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:32:10Z","timestamp":1770453130333,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s15010-018-1130-8","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T14:15:12Z","timestamp":1520345712000},"page":"441-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Essentials in the management of S. aureus bloodstream infection"],"prefix":"10.1007","volume":"46","author":[{"given":"N.","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","volume":"163","author":"VG Fowler Jr","year":"2003","unstructured":"Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066\u201372 (epub 2003\/09\/25).","journal-title":"Arch Intern Med"},{"key":"1130_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s15010-017-0997-0","volume":"45","author":"C Lehmann","year":"2017","unstructured":"Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, et al. The \u201cchoosing wisely\u201d initiative in infectious diseases. Infection. 2017;45:263\u20138 (epub 2017\/03\/16).","journal-title":"Infection"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","volume":"68","author":"AJ Kaasch","year":"2014","unstructured":"Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG Jr, Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J infect. 2014;68:242\u201351 (epub 2013\/11\/20).","journal-title":"J infect"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s15010-016-0883-1","volume":"44","author":"S Rieg","year":"2016","unstructured":"Rieg S, Kupper MF. Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany. Infection. 2016;44:159\u201366 (epub 2016\/02\/26).","journal-title":"Infection"},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/cid\/civ235","volume":"61","author":"BR Palraj","year":"2015","unstructured":"Palraj BR, Baddour LM, Hess EP, Steckelberg JM, Wilson WR, Lahr BD, et al. Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2015;61:18\u201328 (epub 2015\/03\/27).","journal-title":"Clin Infect Dis"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s15010-016-0946-3","volume":"45","author":"M Nagao","year":"2017","unstructured":"Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, et al. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection. 2017;45:83\u201391 (epub 2016\/10\/07).","journal-title":"Infection"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cid\/cix288","volume":"65","author":"AW Karchmer","year":"2017","unstructured":"Karchmer AW. Definitive treatment for methicillin-susceptible Staphylococcus aureus bacteremia: data versus a definitive answer? Clin infect Dis. 2017;65:107\u20139 (epub 2017\/04\/06).","journal-title":"Clin infect Dis"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin infect Dis. 2011;52:e18\u201355 (epub 2011\/01\/07).","journal-title":"Clin infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-018-1130-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T02:35:29Z","timestamp":1551839729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-018-1130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s15010-018-1130-8","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the last 3\u00a0years, NJ has received lecture fees from Labor Stein, Novartis, Gilead, Infectopharm and MSD and travel grants from Gilead, Novartis and Basilea. In the last 3\u00a0years, SR has received lecture fees from Pfizer and Limbach Gruppe SE.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}